Commercialization Venture: an Ontario First model for oncology innovation
HOW IS FACIT UNIQUE?
FACIT brings together entrepreneurial scientists, partner institutions and other key players involved in the commercialization of life science innovations in Ontario. By applying venture capital, market-driven investing principles, our experts identify, access and support technologies with top potential for addressing unmet oncology needs. As an active partner, we provide capital, experienced executive management and connections to our industry and investor network, empowering companies to grow roots and scale in Ontario.
Driving clinical trials, job creation, talent development, sustainable biotech in Ontario
How does FACIT benefit Ontario’s economy, researchers and entrepreneurs?
By accelerating the commercialization of oncology innovations and providing a source of Ontario First capital, FACIT benefits entrepreneurs, researchers, investors and the Ontario economy. We manage Ontario intellectual property and discoveries, keeping skills, talent, leadership, sustainable companies and jobs in the province.
How does FACIT impact patients with cancer?
Our goal is to improve outcomes for cancer patients by getting new therapies, diagnostic tools and other cancer-fighting technologies to market where they can make a difference in people’s lives. Growing Ontario’s oncology innovation economy will ultimately deliver the best cancer care to its patients.
FACIT continues to realize value for money, drive the ecosystem, and transform made-in-Ontario innovations.
(Current As of June 2022)
Ontario start-ups created
in licensing deals
highly-skilled jobs created in Ontario
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.